Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-07-05T18:53:01.147Z Has data issue: false hasContentIssue false

Improving collaboration in primary care-based research: an exploratory case study illustrating current variability in mechanisms for external trials working with primary care research networks

Published online by Cambridge University Press:  31 October 2006

Greta Rait
Affiliation:
Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, UK
Marta Buszewicz
Affiliation:
Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, UK
Irwin Nazareth
Affiliation:
Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, UK
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Primary care research networks are fundamental to developing primary care-based research. A significant amount of their work is with locally organized projects. Working effectively with externally funded trials is another crucial way to inform the evidence base. There is little information on how trial teams may best work with multiple networks. We examined factors that might assist and impede collaboration between an externally funded trial and networks by exploring the systems networks used to assess externally approved trials. A large RCT was used as an example of an external trial. Networks were identified in areas where the trial could provide the intervention. Eighteen networks were sent standard letters asking for information about contacts and assessment procedures. We examined how long it took to identify a liaison person, what processes were used to assess the trial and how long these processes took. Sixteen of 18 networks (89%) agreed to work with the trial. Most networks provided initial information within a month of being contacted. There was no standard process for approving externally funded trials. The time taken to gain final approval varied from one week to three months. There is enthusiasm among networks to work with externally funded studies. It is feasible and can be successful, but current systems for approval are variable and often time-consuming. A defined turnaround time and central mechanism for approving trials could result in greater engagement of external trials with networks and an increased likelihood of a successful research.

Type
Original Article
Copyright
2004 Arnold